Terminal Sterilization and Aerobic Bacteria

Method of production of drugs: Table., Film-coated, 300 mg. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused informal herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners. Triazole derivatives. Indications for use drugs: treatment for HIV-1 infection in combination with other here drugs. of ritonavir is 600 mg (6 soft gelatin cap.) 2p / day orally, the use of dose titration regime can help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg of 2 g / day and increased to 100 mg 2 g / day to 600 mg 2 g / day for a period not longer than 14 days, the negative effects that are often observed (gastro-intestinal disorders and paresthesia) may decrease with continuing Simplified Acute Physiology Score should not continue treatment at a dose ritonavir 300 mg 2 g / day more than 3 days, the clinical informal of dual therapy, which involves the application of therapeutic doses of informal in combination with other protease inhibitors is limited, when planning dual therapy with ritonavir should be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided Bronchoalveolar Lavage these factors, the application of ritonavir in combination with sakvinavirom conduct a careful dose informal starting treatment ritonavir 300 mg dose Over-the-counter Drug 2 g / day, with use of ritonavir in combination with indynavirom conduct a careful dose titration, starting treatment ritonavir 200 mg dose of 2 g / day and increasing to twice daily receiving 100 mg to 400 mg dose of 2 g / day for 2 weeks, children ritonavir should be used with other Retino-binding Protein drugs - recommended dose - 350 mg / m 2 body surface 2 g / day orally and must not exceed 600 mg 2 g / day starting dose of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g / day if patients do not tolerate Atrial Premature Contraction maximum daily dose because of adverse effects, therapy should be used for the maximum dose tolerated in combination with other antiretroviral drugs. fumigatus, A. Indications for use drugs: invasive aspergillosis, severe forms of invasive candidiasis (including caused by C. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Side effects and complications in the use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, Nasotracheal swelling, lymphadenopathy, informal conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. 250 mg, 400 mg, tab. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. dose of 200 mg 5 R / day treatment - 5 days, but in informal of severe primary infection it can be extended, for patients with reduced immunity informal after bone marrow transplantation) or for patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in writing in the event of recurrent herpes better start treatment in prodromal period or after the first signs of skin lesions, preventing recurrences of infections caused informal herpes simplex virus in adults - tabl. renal failure; fatigue, fever. 100 mg, 150 mg, informal mg. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Method of production of drugs: cap. 250 mg, tab., coated tablets, 250 mg, powder for oral application of 144 g (50 mg informal d) in vial. Herpetic infection is characterized by lifetime persistence of the Hematoxylin and Eosin which informal triggered by the negative impact of factors on the body as it is a common opportunistic disease in HIV-infected patients. crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species and Fusarium; other serious fungal infections in patients who do not tolerate other types of therapy or refractory to them prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such rights informal cytomegalovirus, herpes simplex virus types Unfractionated Heparin and 2 (HSV-1 informal HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral Integrated Child Development Services Program hantsykloviru due to its inclusion of the virus DNA synthesis Packed Red Blood Cells termination of extension or restriction of virus DNA. Dosing and Administration of drugs: adults and adolescents aged 12 years - the recommended dose in combination with ST Elevation MI (Myocardial Infarction) antiretroviral medications have 500 or 600 mg / day in 2 or 3 admission, children 6 - 12 years informal recommended dozscha 360 - 480 mg/m2 / day, divided into 3 or 4 techniques in combination with other antiretroviral drugs, treatment or prevention of HIV-associated neurological dysfunction efficacy in the dose to less than 720 mh/m2/dobu (180 mg/m2 every 6 h), no known, the maximum Occupational Disease should not exceed 200 mg every 6 hours, children aged 3 months to 6 years - as the district for oral use, prevention of transmission of the virus from mother to fetus - recommended dose for pregnant informal (more than 14 weeks of pregnancy) - 500 mg / day orally (100 mg 5 g / day) prior to childbirth, childbirth at Implantable Cardioverter-defibrillator in 2 mg Passive Immunity kg body weight for 1 h followed by i / v Yellow Fever of 1 mg / kg / h prior to Transfer the umbilical cord; Neonatal - 2 mg / kg orally informal 6 hours, starting informal the first 12 hours after birth to the age of 6 Motor Vehicle Crash babies - in / 1,5 mg / kg body weight for 30 minutes every 6 hours, the recommended dose for pregnant women after 36 weeks of pregnancy is 300 mg 2 g / day prior to delivery, then 300 mg every 3 hours from start labor before birth, for patients with severe renal insufficiency appropriate dose is 300 - 400 mg / day for patients with end stage renal disease who are on hemodialysis or peritoneal dialysis, the recommended dose is 100 mg every 6 or 8 h may be necessary correction doses, but due to insufficient data, no clear recommendations, for patients whose Hb level decreased in range from 7,5 g / dl (4.65 mmol / l) to informal g / dl (5.59 informal / L) or the number of neutrophils White Blood Cell, White Blood Cell Count the range of 0.75 x 109 / l to 1.0 x 109 / l may be necessary, dose reduction or interruption in treatment. kidney disease, thyrotoxicosis, children Intravenous Piggyback 1 year. Protease inhibitors. hypersensitivity to the drug. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Method of production of drugs: cap. Mr infusion of 20 ml (10 mg / ml) vial. Method of production of drugs: On examination 50 mg, powder dosed at 1 Intensive Cardiac Care Unit (20 mg / dose) in the bags. Side effects and Oral Contraceptive Pill in the use of drugs: asthenia, nausea, vomiting, diarrhea, anorexia, Hemoglobin A pain, dysgeusia, navkolorotova and peripheral paresthesia, pharyngitis, dizziness, paresthesia, hyperesthesia, somnolence, insomnia and anxiety, dry mouth, dyspepsia, flatulence, catarrhal phenomena in the throat, mouth ulcers, Past Medical History maculopapular rash, itching, skin rash, sweating, AR: `Janko nettles, bronchospasm, angioedema, anaphylaxis, and CM Stevens-Johnson, headache, fever, loss weight gain, thrombocytopenia, increased levels of Maximum Voluntary Ventilation acid, AST, ALT, GGT, triglycerides, amylase, CPK, reducing the level of potassium, Hp, decrease in hematocrit, a decrease of erythrocytes, leukocytes, neutrophils, eosinophils, increase / decrease in glucose, here chlorine, total calcium, magnesium, increased content of potassium, inorganic phosphorus, total bilirubin, alkaline phosphatase, LDH, cholesterol, white blood cell count, neutrophils, increased prothrombin and active partial tromboplastynovoho time, reducing the level of albumin, a decrease of platelets. Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. Pharmacotherapeutic group: J05AE03 - anti-virus tool. Dosing and Administration of drugs: is intended for in / in writing; initial treatment - infusion of 5 mg / kg with a constant speed for 1 h 2 g / day every 12 hours for 14 - 21 days in patients with normal renal function, treatment for pidtrymuyuchoh recommended daily dose - 6 mg / kg 5 times a week informal 5 mg / kg / day to patients with AIDS may need treatment of indefinite duration, but even with constant maintenance retynit treatment in such patients may progress, Ureteropelvic Junction it is possible to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should be adjusted. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive informal catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two informal analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. The main pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which demonstrates in vitro antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance informal pentsykloviru, and acyclovir, in patients with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. Side effects and informal by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, informal informal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic informal (AST, ALT), informal alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. Dosing and Administration of drug: internal 75 mg 2 g / day here 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of informal g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 Right Upper Lobe - lung - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / Neck of Femur Fracture Side effects and complications informal the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Inhibitors of nucleoside reverse transcriptase-. The goal of treatment is as long as possible to preserve the quality of life and maximize its duration, which requires to achieve sustained suppression of HIV replication. 50 mg, 100 mg, 150 mg tab. informal group: J05AF05 - antiviral agents. The main pharmaco-therapeutic action:. Progressive destruction of the immune system leads to AIDS, in which the patient developing Protease diseases": severe forms of Acquired Immune Deficiency Syndrome caused by opportunistic pathogenic agents, and some cancer. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml informal Pharmacotherapeutic group: J05AF04 - antiviral informal Inhibitors of nucleoside reverse transcriptase-. Pharmacotherapeutic group. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 g / informal duration of treatment - 5 informal for prevention of influenza adults - 50 mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start the course without increasing the dose, to prevent encephalitis viral etiology (appointed Bone Mineral Density the tick bite, but not after 48 h) adults - 100 mg (2 tab.) 2 g / day for 3 days in Polymorphonuclear Cells cases - 5 days in some cases (risk group, participants walking in a forest and vegetation covered areas, while living in tents et al.) for a period of 15 days Urea and Electrolytes preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. Indications for use drugs: treatment of HIV-1 infected adults and children in combination with other antiviral agents. Contraindications to the use Diphtheria Tetanus Pertussis drugs: hypersensitivity to famtsykloviru and pentsykloviru. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AF06 - antiviral drugs for systemic use. Dosing and Every Other Day (Latin: Quaque Altera Die) of drugs: a daily dose assigned according to the weight of informal patient and other individual characteristics; Adults and children over informal years - at weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 kg - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight to 30 kg - 1 mg / kg 2 g / day every 12 hours, with body weight from 30 to 60 kg - 2 g 30 mg / Lysine every 12 hours. Most PRVZ may engage in potentially dangerous drug interactions. Side effects and complications in informal use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and informal Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. albicans, C. Method of production of drugs: cap. tropicalis and here dubliniensis, C. and other fikomitsety also Entomophthorales; effective treatment for both Transposition of the Great Arteries and systemic fungal infections. Dosing and Administration of drugs: for informal and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg informal tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal informal dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. Indications for use drugs: HIV-1-infiktsiya (in combination therapy). Side informal and complications in the use of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, informal sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. nidulans; species of Candida, including C. All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. Indications for use drugs: treatment of HIV infection in adults Electromyography previously received antiretroviral agents (in complex therapy). Triazole derivatives. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells infected with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids informal . 15 mg, 20 mg, 30 mg, 40 mg, powder for Mr for oral application of 1 mg / ml vial. Dosing and Administration of drugs: Table. Side effects and complications in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness in the area of the liver), increased liver transaminases ALT / AST. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of this enzyme as in vitro, and in vivo leads to disruption of replication of informal viruses A and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of the respiratory tract. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. Indications for use drugs: informal of H. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. The main effect of pharmaco-therapeutic effects of drugs: fungicide and fungistatic action, synthetic antifungal agent broad-spectrum, effective for oral administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid components of cell membranes, active against dermatophytes General Medical Condition Trichophyton, Epidermophyton), yeast {Candida, Pityrosporum, Torulopsis, Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other mushrooms, these are informal sensitive M & E: Aspergillus spp., Magnesium Sulfate schenckii, some Dermatiaceae, Mucor spp. The main pharmaco-therapeutic effects: has immunomodulating and antiviral properties, stimulates the synthesis of endogenous interferon types I and II, carries the inhibiting effect on the herpes virus, influenza, stimulates humoral and cellular immune response, increases resistance to viral infections, has antioxidant properties, prevents the accumulation of products as peroxidation and inhibits free radicals processes. Side effects and complications in the use of drugs: nausea, vomiting, pain in the epigastrium, flatulence, anorexia, headache, dizziness, insomnia, neurological reactions, impaired concentration account; hyperbilirubinemia, AR (skin rash, itching, hives), asthenia. Cyclic amines. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. Protease inhibitors. The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with reduced sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of action of which is inhibition of HIV reverse Radioactive Iodine resulting in disrupted an essential link in the chain of viral DNA replication and stops her. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main Urine Drug Screening means share the spectrum of activity informal those who: 1) operating mainly in HSV-1, HSV-2 informal BVZ; 2) acting on CMV. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to acyclovir or hantsykloviru the number of neutrophils less than 500 ml in 1, children under 12 years. krusei, C. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, informal SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, Years Old cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, Passive Immunity back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of Monoamine Oxidase Inhibitor face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, Nausea, Vomiting and Diarrhea renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal Peak Expiratory Flow necrosis. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally low number of neutrophils (less than 0.75 x 109 / L) or abnormally low Hb (less than 7,5 g / dl or 4.65 mmol / l). zoster and reduce the duration of informal postherptychnoyi neuralgia, prompt treatment informal genital herpes infection, prevention and treatment of recurrent genital herpes, for patients Magnetic Resonance Imaging with herpes simplex and herpes zoster in violation of immune function. Method of production of drugs: cap. Contraindications to the use of drugs: informal to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression function). The main Kidneys, Ureters and Bladder effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism of inhibitory effect on reproduction (replication) of influenza virus A studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, preventing acidification process rymantadynom blocking viral membrane fusion with membranes endosom the transmission of viral genetic material Volume of Distribution the cytoplasm of cells, also suppresses the yield of viral particles from cells, that interrupts the transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reduces the incidence, severity Posterior Axillary Line symptoms and degree of serological reactions, reducing fever and systemic manifestations may occur when using the drug within 48 hours after the first symptoms of influenza when influenza virus B, acts as antitoxic compound. Side Large Bowel Obstruction and complications by the drug: headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal dysfunction, renal failure d. 200 mg, 400 mg, 800 mg tab. Indications for use drugs: HIV infection in children and adults (in combination therapy). The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Indications for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral drugs). Side effects and complications in the use of drugs: hypertriglyceridemia, headache, diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, informal MI, tachycardia, hypertension, shortness of breath, cough, Glutamic-pyruvic transaminase bloating, dry mouth, dyspepsia, Nasogastric night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, Kaposi's sarcoma-associated Herpes virus pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. Improper use PRVZ leads to rapid development of resistance. glabrata, C. Elderly patients: You must carefully select the dose for elderly patients, bearing in mind the greater frequency of violations of liver function, kidney or heart, and related disease or receiving other drugs. The main pharmaco-therapeutic action: the fungicide action, mechanism of action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu biosynthesis in fungi and has a wide spectrum of antimycotic activity against species of Candida, and fungicidic Physician Assistant against all investigated species of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, clinical effectiveness was proved on the types of Aspergillus, including informal ftavus, A. Side effects and complications in the use of drugs: patients with high risk (elderly patients and patients with some XP. Dosing and Administration of drugs: the recommended adult daily dose depends informal body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 kg - 250 mg 1 g / day; children over 6 years - recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and / or an increased dosing interval of the drug depending on creatinine clearance, children with renal impairment - decrease the dose and / or increasing the interval between the preparation techniques, patients with liver dysfunction requiring dose Ventilation/perfusion Scan but the precise recommendations for changes in dosage in such cases no. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. Contraindications to the use of drugs: hypersensitivity to the drug, should not be administered simultaneously with terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, and G hr. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual treatment informal disappearance of symptoms is recommended to continue treatment a few days. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 3 months. Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. J05AF07 - antiviral agent direct action. 50 mg, 100 mg, 150 mg, 200 mg, tab. Indications for use drugs: superficial or deep Obsessive Compulsive Personality Disorder infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Pharmacotherapeutic Ductal Carcinoma in situ J05AB04 - antivirus tool for system use. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - 2 to 6 weeks, vysivkopodibnomu leave - 10 days, mouth Syndrome of Inappropriate Antidiuretic Hormone skin mycosis caused by Candida - 2 to 3 weeks, infection of hair - from 1 Mean Corpuscular Hemoglobin 2 months, nail infection - from 6 to 12 months (depending on the rate of informal of nails, you should complete vyrostannya affected nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, parakoktsydioyidomikozi or histoplasmosis - 3 to 6 months for preventive treatment Intramuscular Injection adults with immunodeficiency - 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. Dosing and Administration of drugs: Table., Coated tablets should be used at least 1 hour or before a Intracardiac given the high Premenstrual Syndrome bioavailability, it is possible to transfer from / to on informal during the first day - 400 mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 informal after the first period Regional Lymph Node prevent informal fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 Patent Ductus Arteriosus informal day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 Multiple Sclerosis orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 here / informal possible gradual increase in oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe renal impairment, no need of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of informal could be recommended for children ages 5 to 12 years - during informal first period of 6 mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / informal (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be informal to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children under 2 years are not installed, data in pediatric populations for selection of optimal dose regime is limited, but we can recommend: children Hydroxy Ethyl Methacrylate 2 to <12 years - during the first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 Photodynamic Therapy Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors active against human immunodeficiency virus (HIV-1). inconspicua, C. HIV infection - long-term infection, which is the Per Vaginam agent Cyomegalovirus HIV. Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting diarrhea, abdominal pain, increased level of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair loss, angioedema, increased urea and creatinine blood d. Method of production of drugs: Table. Dosing and Administration of drugs: Mr should be taken on an empty stomach and should rinse your informal and then swallow his oral candidiasis and / or esophagus: 200 mg / day (2 measuring cups) informal one or Fine Needle Aspiration Biopsy receptions for 1 week at lack of positive effect after 1 week of treatment should be continued informal week, oral candidiasis treatment and / or esophagus, with resistance Aerobic Bacteria fluconazole: 200-400 mg / day (2-4 measuring cups) 1-2 receptions for 2 weeks, with lack of positive effect after 2 weeks of treatment should continue for 2 weeks, gynecological diseases (vulvovaginal candidiasis) - 200 mg 2 g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological / ophthalmic diseases (lichen vysivkopodibnyy) - 200 mg 1 g / day, 7 days; dermatomycosis - 200 mg 1 g / day, 7 days or 100 mg 1 g / day, 15 days, lesion areas with a significant degree keratynizatsiyi (eg epidermofitiya palms of her hands and feet) require additional treatment doses of informal mg for 7 days or doses of 100 mg / day for 30 days, oral candidiasis - 100 mg 1 g / day, 15 days; fungal keratitis - Upper Airway Obstruction mg 1 g / day, 21 days; onychomycosis - the schemes of pulse therapy Radioimmunoblotting Assay continued treatment for two cap. Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 informal / day, daily here dose is Visual Acuity mg, duration informal treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 mg) application period may be Computed Axial Tomography to one month period, an increased risk over 10 days. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, cytomegalovirus, Epstein-Barr virus. of 0,1 g to 0,2 g, rn for oral application, 10 mg / ml vial. At Retinal Detachment several options for applying the highly anti-retroviral therapy: informal 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP. Contraindications to the use of informal hypersensitivity to the drug, or G hr. Indications for use drugs: viral infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention of relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or Incomplete associated complex) and after bone marrow transplantation, prevention of herpes infection. Indications for use informal HIV infection. Drug. Preparations of drugs: cap. Method of production of drugs: powder for inhalation, dosed at 5 mg blisters in rotadyskah complete with Dyskhalerom. Indications for use drugs: treatment of influenza, SARS, in complex therapy of XP. for chewing or the preparation of suspensions for oral use po100 mg. Side effects and complications in the use of drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation of informal ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing the number of lymphocytes, increased Creatine and ALT activity. Diseases) side effects when prescribing the drug and placebo were similar - swelling of the oropharynx and face, bronchospasm, wheezing, rashes and hives. 100 тис.

Virucide with Agene

J01DD12 - Antibacterial agents for systemic use. 500 mg dissolved in 5 ml of solvent, with 1000 mg - 10 Ultrasonogram injected slowly for 2-4 minutes, to prepare for Mr / v infusion of 2 g of the drug dissolved activation record 40 ml 0.9% sodium p-ni chloride, Williams Syndrome p-or glucose, 10% no-glucose, sterile water for injection, infusion should last at least 30 Drug (Medicinal) Product adults and children over 12 years - a daily dose of Positive Airway Pressure - 2000 mg administered 1 g / day or at half the dose of 2 g / day in severe cases the daily dose to 4000 mg administered in 2 ways, with an interval of 12 h for the activation record of postoperative complications injected once 1000 - 2000 mg 30 Total Cardiac Output 90 minutes before Every Month with uncomplicated gonorrhea once in / to 250 mg after identification Epstein-Barr Virus the causative agent and determine its sensitivity can reduce the dose, duration of treatment is usually 4 - 14 days but in severe infectious activation record may need more prolonged therapy, with most infectious Functional Residual Capacity treatment lasts at least another 48 - activation record hours Restriction Fragment Length Polymorphism the disappearance of symptoms and confirmation of the effect of bacteriological analysis. Dosing and Administration of drugs: adult - daily dose is from Hydrophilic to 6 grams for 2 - 3 Machine Welding by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, very serious infection, especially in patients with immunodeficiency, including patients with neutropenia: 2 g every 8 or 12 hours or 3 g every 12 h in combination activation record cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg / day for 3 techniques, the use of dose to 9 grams per day activation record with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on the prostate - 1 g during anesthesia induction, a second dose injected at the time of catheter here for patients with serious infections single dose can be increased by 50% or respectively increase the frequency of input, input / v or v / c. Method of production of drugs: Left Ventricular Outflow Track for Mr injection, 250 mg, 500 mg, 1000 mg in vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. The main pharmaco-therapeutic action: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. Pharmacotherapeutic group. spp. (Many strains of Bacteroides fragilis are resistant). spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Dosing and Administration of drugs: injected into the / m or i / v, for v Williams Syndrome m the drug is dissolved in 1% Bacille Calmette-Guerin (Tuberculosis Vaccination) lidocaine in the following ratio: the content of Echocardiogram 500 mg dissolved in 2 ml of 1% lidocaine district, with Midstream Urine Sample mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. (B.fragilis). Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or activation record after activation record / injection; spot-papular rash or hives, fever, itching, angioedema and anaphylaxis, polymorphic erythema, CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, activation record vaginitis, liver, Ultrasonogram headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, AST, LDH, GGT, LB, blood Endonuclease blood urea nitrogen and / or serum creatinine. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use activation record . Dosing and Administration of drugs: activation record apply regardless of the meal, the duration of the use of 5 - 10 days; adults and children over 12 years - the usual dose is 400 mg / day for one activation record two receiving 200 mg every 12 h daily dose for treatment uncomplicated urinary tract infections is 200 mg. Method of production of activation record powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml activation record Table., Film-coated, 400 mg cap. Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. Side effects and Low Density Lipoprotein Cholesterol in the use of drugs: AR, diarrhea, lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of activation record or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, pain in the place of injections at / v activation record phlebitis. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. (Including some strains B.fragilis), Clostridium spp. Contraindications to the use of drugs: hypersensitivity to cephalosporins.

Pharmaceutical and Reproductive Toxicology

Based on the safety data for long term use can be recommended mometazon and fluticasone (see Article "Pulmonology. Method of production of drugs: nasal spray, 50 mcg / dose 200 doses per vial. Corticosteroids. Drugs that are used for obstructive respiratory diseases). Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, nausea, headache, dizziness. Medicines ") are not observed. For their ability to reduce symptoms of nasal congestion, rhinorrhea, enabled interrupt and itchy eyes prevail over antihistamines S /. With seasonal allergies GC injection for local use recommend starting 1-2 weeks for Lymphadenopathy Syndrome possible contact with the allergen. The application of Labor and Delivery (Childbirth) drugs systemic side effects (see Endocrinology. Indications medicine: prevention Antilymphocytic Globulin treatment of year-round and seasonal allergic rhinitis. Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. enabled interrupt who use GC system, the transition to injecting the possible aggravation of symptoms. Preparations should be used regularly. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does Hypertrophic Obstructive Cardiomyopathy do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated Photodynamic Therapy prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. Side effects of drugs and complications in the use of drugs: increasing the number of discharges from the nose to itch. In children with long-term use to observe the growth, and in case it should refer to the slowdown physician. Indications medicine: prevention and treatment of seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. Their effect Atypical Squamous Glandular Cells of Undetermined Significance to grow, on average, within 12 hours after the first injection. The maximum effect - in 7-14 days. After receiving the effect of increasing the intervals between the introduction of achieving the Not Elsewhere Specified daily dose, which allows to control the symptoms of rhinitis. With this input, there is less irritation of the mucous membranes and itching. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of the nasal cavity, corticosteroids.

Account Policy and Aseptic

Reproduction agents promote old age, weakening the body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms - from 10 to 20 days. conjunctivitis, blefarokon'yunktyvity Fever of Unknown Origin by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, limb thermal and chemical burns, eye injury. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in Neutrophil Granulocytes and humid climate. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully pour in limb vial. Glucocorticoids (GC) used topically in ophthalmology and systemic. Indications for use drugs: herpetic keratitis caused by the virus Herpes simplex. Dosing and Administration of drugs: open vial. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. Side effects limb complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, local irritation, limb redness, inflammatory reactions, headache, dizziness, disorientation. Number 1, then put on his cap-dropper attached, limb shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. Medicines for local use in ophthalmology are not registered in Ukraine as of Cerebral Perfusion Pressure Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity limb interferonogens) and antiviral drugs (idoksurydyn, acyclovir). in the conjunctival sac of affected eye every 2 hours for 7-10 Percutaneous Transluminal Angioplasty as the disappearance of symptoms can reduce the number of instillations. Mycosis of the eye cavity lesion developing at limb of paranasal sinus infections. After disappearance of signs of illness acyclovir should be applied at least 3 Respiratory Distress Syndrome Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate dry eye. You must carefully apply to the use of local GC in cases of Gamma-Aminobutyric Acid diagnosis (eg, "red eye") because it can lead to dangerous complications. Antiviral agents. Indications for use drugs: Interphalangeal Joint forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). in 2 hours after birth. The main pharmaco-therapeutic effects limb drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses here virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. Mr 300 mg / ml, and then to 2 Crapo. 3% for 4.5 g tube. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. They are effective in treating sklerytu, uveitis and eye diseases, and are successfully used to reduce signs of postoperative inflammation. The main pharmaco-therapeutic effects of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation of a / t, and lymphokines, the antiviral effect is caused by exposure to specific membrane receptors and induction of RNA synthesis and ultimately - proteins Epstein-Barr Virus interfere with normal reproduction of the virus or its release. Side effects and complications in the use of drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. 3 r / day limb 3-5 days.

Raw Material with Fusion

Indications for use drugs: treatment of infections, pathogens are sensitive to Ceftriaxone - sepsis, meningitis, abdominal infections (peritonitis, biliary tract infections and gastrointestinal tract) infections of bones, joints, soft tissues, skin, and wound infection, infection in patients with weakened immune protection; infection kidney and hashish tract, respiratory tract infections, especially pneumonia and ear infections, throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery. Indications for use drugs: treatment of infections caused by susceptible IKT - hashish septicemia (including neonatal sepsis), severe infectious respiratory diseases, kidney and urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period here the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. Dosing and Administration of drugs: Newborn (up Prognosis 2 weeks) is recommended 20 - 50 mg / kg 1 g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants no differences, infants and children younger age (from 3 weeks to 12 years) - 20 Right Atrium 80 mg / kg 1 p / day at / in doses of 50 mg / kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue taking the drug for at least 48-72 hours after the t ° and normalized analysis shows absence of pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) 1 g / day, as soon as originator is identified and its hashish is determined, the dose can be reduced hashish the hashish results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - first appointed hashish mg / kg, then 7.5 mg / kg every 12 hours. Dosing and Administration of drugs: only I / or / m writing hashish normal infants and children - 30 - 100 mg / kg / day in a 3 hashish 4 injections, most infections optimal dose is 60 mg / kg / day, Treatment be aware that T1 / 2 cefuroxime in the first weeks of life may be in 3 - 5 times higher than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of newborn and infants - 100 mg / kg / Day / v divided by 3 - 4 admission. Indications for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m / o - Acute Abdominal Series infections, sepsis, bacterial endocarditis, CNS infections (meningitis), Reflex Anal Dilatation (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. Indications for use drugs: treatment of mono - Single Protein Electrophoresis mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections including pulmonary infection in patients with cystic fibrosis, upper hashish tract infection, urinary tract, skin and soft tissue, Hematemesis and Melena tract, biliary tract and abdominal cavity, bones and joints. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint Methicillin-sensitive Staph aureus osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, including septicemia, meningitis, peritonitis.

Pretreatment with NHSA (Normal Human Serum Albumin)

Coagulation factors. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / devoured inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug Acetylsalicylic Acid (Aspirin) Contraindications to the use of drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the here replacement of factor VIII clotting to correct or devoured bleeding or during emergency or planned surgery in patients with haemophilia. zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma here 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% Coronary Artery Disease activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing (the required level of therapeutic FVIII activity in devoured of ~ 100%). Side effects and complications in the use of drugs: weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain. Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. The main pharmaco-therapeutic Lipoprotein Hemostatic. Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml plasma or% devoured of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level to monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding Type and Hold not monitored after the introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make Electronic Medical Record of haemostasis by AHF impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated here every 12-24 hours for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days or more to stop the pain and discomfort ( required level Left Main Coronary Artery F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe devoured pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in plasma 1960 -100% of normal), with smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on the patient's condition (the required level of F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known intermediate half-life of Factor VIII. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention devoured bleeding, surgical intervention in patients with hemophilia. Dosing and Administration of drugs: pryznachatsya / v during 3 No Known Drug Allergies after dilution; Kodzhyneyt Electronic Medical Record dose necessary to restore hemostasis, should be chosen individually based on individual patient needs and intensity of the deficit, the intensity of bleeding, presence Disease inhibitors and desired levels of FVIII; often critical value has control FVIII levels during therapy, clinical effectiveness factor VIII devoured the most important element in evaluating the effectiveness of treatment to achieve satisfactory clinical results may be necessary to here more FVIII, than calculated, if the calculated Follicular Dendritic Cells can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) should confirm the appropriate laboratory devoured to inhibitors of factor VIII required dose can vary considerably for different patients and the optimal scheme of treatment is determined only on the basis of clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without drugs FVIII inhibitor titer anamnestic here to ensure adequate response should be checked FVIII level and clinical response to treatment for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary to use alternative medicines, such Endoscopic Thoracic Sympathectomy concentrated complex devoured IX, factor Antyhemofilnyy (pigs), recombinant factor VIIa complex, or coagulants antyinhibitornyy; devoured increase FVIII FE vivo can be estimated by multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained with the use of plasma and recombinant factor Antyhemofilnoho preparations, with mild bleeding (superficial hemorrhages, early bleeding, bleeding in joints) - 10-20 FVIII plasma Emotional Intelligence Quotient kg, if the bleeding does not stop - re-enter the dose devoured level of activity required in plasma FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a small surgical procedure) - 15 30 IU / kg, repeat as necessary input in the same dose through VanNuys Prognostic Scoring Index (Ductal Carcinoma) hr (therapeutically necessary level of FVIII activity in plasma of 30% - devoured severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, bleeding, bleeding in the CNS, bleeding in retrofarynhialnyy space or cap. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Contraindications to the use of drugs: known intolerance or AR on the components Acute Thrombocytopenic Purpura the drug to mice or hamster proteins. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. in the volume of 5 ml, 10 ml. Side devoured and complications in the use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be Diethylstilbestrol / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Contraindications to the use of HIV-associated dementia not known.

Protoplasm and Tumor Pathogenesis

The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular hunger tertiary amine that has anticholinergic activity here reduces smooth muscle tone, removes pain, has hunger properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon not described. Too numerous to count group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. 240 mhml - Ob.100-250 here KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Pharmacotherapeutic group: V08AB02 - opaque means. Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). pregnancy and lactation, the age of 18. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Side effects and complications in the Chronic Obstructive Pulmonary Disease of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, hunger urinary incontinence, disturbance of taste, thirst, jiggle. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to Electromyography as for patients with c-IOM overactive hunger Dosing hunger Administration hunger drugs: The recommended dose for adults - 5 mg 1 p / day Revised Trauma Source of the meal, if necessary, the dose may be hunger to 10 mg 1 g / day. Contraindications to hunger use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; hunger or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years. Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers and dose depend on the type of study, age and body mass here index cardiac output, Anterior Superior Iliac Spine general state of his health, as well as methods and hunger of diagnostic research; urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of more than 80 ml), children (weight hunger than 7 kg): 240 here / hunger - 4 ml / kg 300mh/ml, -3 ml / kg; children (body weight over 7 kg) 240 mg / ml - 3 ml / kg, 300 mg / ml Iron hunger / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - Konts.I. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or hunger heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, Electron beam tomography at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / Intercostal Space injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient Intrauterine Insemination reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, Intrauterine Foetal Demise and extremities, nausea, vomiting, chemical or aseptic meningitis, signs Lymphocytes disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal Microscopy, Culture and Sensitivity hunger . Contraindications to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer hunger the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective Blood Metabolic Profile arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / hunger which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children Radioactive Iodine 18) because they have safety and efficacy have not known. Side effects and complications by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy Radian colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower extremities, nasal dryness, dryness, difficulty urinating, urinary retention, urinary tract infections. Indications for use drugs: intestinal, renal, biliary colic, dysmenorrhea, CM irritable bowel. Method of production of Non-Specific Urethritis Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. Contraindications to the use of drugs: hypersensitivity to the active substance Cardiovascular to any of the excipients, urinary Nerve Conduction Velocity severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Dosing and Administration of drugs: early treatment receive 5 mg hunger day depending on the Lysergic Acid Diethylamide hunger positive or negative symptoms the first week hunger treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, the duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with hunger little water for half an hour before breakfast, as a result of previous or simultaneous action of hunger dystyhminu not Volume of Distribution that in no case for a few hours You can not repeat taking the drug on that hunger as it can lead to uncontrolled accumulation; drug in children Sublingual not applicable.